Skip to content
HOME Insights

Ncyte® NHP-C vCardiomyocytes Poster

Development and Characterization of Non-Human Primate iPSC-Derived Ventricular Cardiomyocytes for High-Throughput Safety Pharmacology Screening
Download now
2025OCT15_SPS_NHP_POSTER_V2

This poster highlights the development, characterization and application of Ncyte® NHP-C vCardiomyocytes, addressing a critical translational gap in nonclinical safety pharmacology.

Download it now for an exclusive look at:  

  • Why NHP-derived cardiomyocytes are needed to improve cross-species translation in cardiac safety testing 
  • How Ncardia’s proprietary 3D bioreactor and robust assay platforms ensure reproducibility, scalability, and predictive power
  • Data highlights including flow cytometry, MEA and impedance assays and comparative pharmacology tests
Download the Poster
Topics
Get the Poster Now!

Whether you need to optimize safety pharmacology or enhance translational research, this poster provides detailed evidence of how Ncyte® NHP-C vCardiomyocytes can de-risk development and align with regulatory expectations.  

Download the poster by filling the form below: